Platelet and Endothelial Dysfunction in Psoriasis

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Psoriatic Arthritis
    Psoriasis
  • Age: Between 18 - 90 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    Psoriatic Patients:
    1. Participants with psoriasis or psoriatic arthritis as confirmed by a board certified dermatologist or rheumatologist.
    2. Hidradenitis suppurativa (HS) participants as confirmed by a board certified dermatologist.
    3. Participants who are between 18 and 90 and provide written informed consent for the study
    Healthy Control:
    1. Participants who are between 18 and 90 and provide written informed consent for the study

You may not be eligible for this study if the following are true:

  • Psoriatic Patients:
    1. Rheumatologic or inflammatory disease which are not psoriasis or psoriatic arthritis or HS
    2. Known active cancer receiving treatment
    3. Pregnancy
    4. Anemia
    5. A history of severe bleeding or bleeding disorders
    6. Chronic kidney disease
    7. Congestive heart failure
    8. NSAID use within the past 48 hours or aspirin use within 2 weeks of study enrollment
    Healthy Control:
    1. Autoimmune, rheumatologic or inflammatory disease which are not psoriasis or psoriatic arthritis
    2. Known active cancer receiving treatment
    3. Pregnancy
    4. Anemia or thrombocytopenia or thrombocytosis
    5. A history of severe bleeding or bleeding disorders
    6. Chronic kidney disease
    7. Congestive heart failure
    8. NSAID use within the past 48 hours or aspirin use within 2 weeks of study enrollment



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.